To explore the effect of HMGB1 on GBM cells, we compared transcriptomes of GBM cells treated with rhHMGB1 (800 ng/ml, 48 h) with the control (PBS-treated) by RNA-seq. The gene discussed is HMGB1; the disease is glioblastoma.